AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2021
May 11, 2021
32870_dirs_2021-05-11_3d14218b-d167-4153-8eb5-c37926c561e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2021-05-10
Reporting Person: SULLIVAN LOUIS W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-10 | Common Stock | M | 10305 | $18.64 | Acquired | 43063 | Direct |
| 2021-05-10 | Common Stock | F | 3118 | $61.62 | Disposed | 39945 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-10 | Employee Stock Options (Right to Buy) | $18.64 | M | 10305 | Disposed | 2021-05-21 | Common Stock (10305.0) | Direct |
Footnotes
F1: Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock option exercise.
F2: Consists of an option granted under the company's stock incentive plan as amended and restated.
F3: The option vested in three equal installments in May 2015, May 2016 and May 2017. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.